XT
IMUX icon

XTX Topco’s Immunic IMUX Stock Holding History

XTX Topco’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,082
Closed -$34.2K – 4409
2026
Q1 		$34.2K Sell
3,082
-19,445
-86% -$174K ﹤0.01% 3420
2025
Q4 		$120K Buy
+22,527
New +$165K ﹤0.01% 2586
2025
Q1 		– Sell
-1,568
Closed -$15.7K – 2711
2024
Q4 		$15.7K Sell
1,568
-1,328
-46% -$16.7K ﹤0.01% 2083
2024
Q3 		$47.8K Sell
2,896
-3,319
-53% -$47.3K ﹤0.01% 1700
2024
Q2 		$69K Buy
6,215
+45
+0.7% +$559 0.01% 1473
2024
Q1 		$81.4K Buy
6,170
+1,942
+46% +$25.2K 0.01% 1397
2023
Q4 		$63.4K Buy
4,228
+1,714
+68% +$21K 0.01% 1201
2023
Q3 		$37K Sell
2,514
-19,431
-89% -$374K 0.01% 1312
2023
Q2 		$551K Buy
21,945
+14,868
+210% +$249K 0.1% 311
2023
Q1 		$105K Buy
+7,077
New +$131K 0.02% 1095
2022
Q3 		– Sell
-1,997
Closed -$69K – 1229
2022
Q2 		$69K Buy
+1,997
New +$128K 0.03% 714

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

XTX Topco's IMUX Position: Q2 2026 in Review

XTX Topco sold out of Immunic (IMUX) in Q2 2026, closing a stake of 3,082 shares — an estimated $34.2K sold.

XTX Topco first reported a position in IMUX in Q2 2022 and held it in 11 quarters. The position peaked at $551K in Q2 2023. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • XTX Topco reported no remaining Immunic position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 3,082 Immunic shares in Q2 2026, an estimated $34.2K.
  • XTX Topco first reported a position in Immunic in Q2 2022 and held it in 11 quarters.
  • XTX Topco's Immunic position peaked at $551K in Q2 2023.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.